A facility for safe research on dangerous pathogens
BSL-3 Practices Core
The University of Tennessee Health Science Center is working on making sure that research with dangerous germs is done safely, so scientists can better understand and treat infections that affect people like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10910182 on NIH RePORTER |
What this research studies
The University of Tennessee Health Science Center's Regional Biocontainment Laboratory (RBL) focuses on maintaining a safe environment for research involving potentially harmful bacteria, viruses, and fungi. This facility is equipped with specialized management, engineering controls, and trained staff to ensure compliance with biosafety standards. The BSL-3 Practices Core aims to streamline operations, enhance communication among safety teams, and ensure that all research conducted meets rigorous safety and security protocols. By facilitating research that requires high-level containment, the RBL supports critical studies that could lead to advancements in understanding and treating infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include researchers and healthcare professionals working with infectious diseases that require BSL-3 containment.
Not a fit: Patients who are not involved in research or do not have conditions related to infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance the safety and efficiency of studies on infectious diseases, potentially leading to new treatments and preventive measures.
How similar studies have performed: Other research facilities with similar biosafety practices have shown success in advancing our understanding of infectious diseases, indicating that this approach is effective.
Where this research is happening
Memphis, United States
- University of Tennessee Health Sci Ctr — Memphis, United States (Active)
Researchers
- Principal investigator: Kong, Ying — University of Tennessee Health Sci Ctr
- Study coordinator: Kong, Ying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.